THE CURE INDEX
Helio Cure's evidence score based on human clinical trials for red light therapy.
Age-related muscle loss, also called sarcopenia, describes the gradual decline in muscle mass and strength that occurs with age.
Across 6 human studies and 182 participants, the evidence on red light therapy for age-related muscle loss came back mixed. This condition received a CURE Index score of 31 out of 100, indicating limited confidence.
Some participants experienced less muscle fatigue and small gains in muscle size after red light therapy, though the therapy did not reliably improve muscle strength or physical performance in most studies.
All 6 studies were randomized controlled trials. Of these, 2 studies found the therapy effective, 1 found it partially effective, and 3 found no meaningful benefit.
Studies most often used a wavelength of 808 nm, within a broader range of 630 to 850 nm. Treatment sessions lasted 40 to 70 seconds and were administered 2 times per week over periods ranging from 7 to 84 days.
EVIDENCE AT A GLANCE
The numbers behind the verdict.
MOST CITED WAVELENGTH
The wavelength appearing most often in studies that showed benefit for age-related muscle loss.
808 nmTREATMENT PROTOCOL RANGES
The lowest and highest values used across age-related muscle loss studies.
| PARAMETER | RANGE |
|---|---|
| Wavelength | 630-850 nm |
| Session Duration | 40-70 seconds |
| Therapy Duration | 7-84 days |
Note: We have excluded meta-analyses and reviews from scoring, but the list of human studies below contains them for your reference.
7 Human Studies on Red Light Therapy for Age-Related Muscle Loss
Elderly Women Showed Less Fatigue After Light Therapy for Muscle Loss
According to a 2016 randomized double-blinded placebo-controlled human trial, photobiomodulation (PBM) was evaluated for age-related muscle loss in elderly women. The trial included 30 participants with an average age of about 63.7 years, comparing active PBM against an identical placebo session, both applied to the front thigh muscle of the dominant leg at 808 nm, 100 mW, 250 J/cm2, 35700 mW/cm2, and 56 J of total energy for 70 seconds per point, 2 times per week for 7 days, immediately before a fatigue test that measured electrical muscle signals, blood lactate, and strength on a testing machine. A stronger electrical fatigue signal and lower blood lactate after exercise were reported for active PBM compared with placebo in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 30
- Treated Area
- Thigh
- Wavelength(s)
- 808 nm
- Session Duration
- 70 seconds
- Session Frequency
- 2 per week
- Therapy Duration
- 7 days
Study Title: Effects of photobiomodulation on the fatigue level in elderly women: an isokinetic dynamometry evaluation.
Laser Therapy Increased Exercise Repetitions in Age-Related Muscle Loss
24 elderly women, tested in a 2013 human randomized triple-blinded placebo-controlled crossover trial, completed a knee extension fatigue protocol after receiving active or placebo low-level laser therapy (LLLT) for age-related muscle loss. Active LLLT, delivered at 808 nm, 100 mW, and 7 J to the thigh muscle immediately before the fatigue protocol, was compared with an identical placebo LLLT session in each participant, who performed repeated knee extension movements at 75% of their maximum repetition load for 60 seconds while electrical muscle signals measured muscle fatigue. Researchers found that active LLLT was associated with a higher number of repetitions during the fatigue test compared with placebo in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 24
- Treated Area
- Thigh
- Wavelength(s)
- 808 nm
Study Title: Effect of 808 nm low-level laser therapy in exercise-induced skeletal muscle fatigue in elderly women.
Review Found Mixed Benefits From Photobiomodulation for Muscle Loss
Comparing active photobiomodulation (PBM) therapy against placebo or control conditions across 10 studies, researchers conducted a 2024 scoping review addressing age-related muscle loss in older adults. The included studies applied laser or LED light from 638 to 850 nm mainly to the thigh muscle, at irradiance levels from 2000 to 35700 mW/cm2 and doses from 11.7 to 892 J/cm2, in sessions of 20 to 70 seconds performed 2 to 3 times per week over 28 to 84 days, among 390 older adults aged 60 and older, most of them women. In the end, the review reported that PBM therapy provided some added benefit as an adjunct to resistance training for certain outcomes, such as reduced fatigue, in older adults.
- Study Type
- Review
- Participants
- 390
- Treated Area
- Leg
- Wavelength(s)
- 638, 808, 850 nm
- Distance
- Contact
- Session Duration
- 20-70 seconds
- Session Frequency
- 2-3 per week
- Therapy Duration
- 28-84 days
Study Title: Photobiomodulation therapy as an adjunct to resistance exercises on muscle metrics, functional balance, functional capacity, and physical performance among older adults: A systematic scoping review.
Photobiomodulation Showed Modest Muscle Growth Benefit for Age-Related Muscle Loss
Improvement scores for muscle growth reached 0.58 for active laser photobiomodulation (PBM) therapy and 0.38 for the placebo leg in a 2022 randomized, triple-blind, placebo-controlled trial addressing age-related muscle loss in older women. The trial enrolled 22 women with an average age of 66.6 years, each contributing one leg randomly assigned to active 808 nm PBM at 100 mW and 42 J and the other leg to a placebo laser, alongside supervised resistance training performed 2 times per week for 70 days. The study reported that active PBM was associated with more muscle growth than placebo in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 22
- Treated Area
- Leg
- Wavelength(s)
- 808 nm
- Session Frequency
- 2 per week
- Therapy Duration
- 70 days
Study Title: Effects of Photobiomodulation/Laser Therapy Combined With Resistance Training on Quadriceps Hypertrophy and Strength, and Postural Balance in Older Women: A Randomized, Triple-Blinded, Placebo-Controlled Study.
Resistance Training Plus Photobiomodulation Matched Training Alone for Muscle Loss
34 post-menopausal women took part in a 2020 randomized controlled trial evaluating photobiomodulation (PBM) added to resistance training for age-related muscle loss. Both groups trained 2 times per week for 56 days, with the resistance training group of 17 receiving a placebo device and the photobiomodulation group of 17 receiving 630 nm and 850 nm light at 100 mW and 4 J per diode, applied in contact with the front of the thigh for 40 seconds per session. No added improvement in muscle strength was reported for the light therapy group compared to resistance training alone in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 34
- Treated Area
- Thigh
- Wavelength(s)
- 630, 850 nm
- Distance
- Contact
- Session Duration
- 40 seconds
- Session Frequency
- 2 per week
- Therapy Duration
- 56 days
Study Title: Effects of photobiomodulation on muscle strength in post-menopausal women submitted to a resistance training program.
No Added Benefit From Photobiomodulation Therapy for Age-Related Muscle Loss
Researchers compared placebo and active photobiomodulation therapy (PBMT) groups in a 2019 randomized double-blinded placebo-controlled trial addressing age-related muscle loss in elderly men. The trial included 24 healthy men aged 60 to 80, split into a placebo group of 13 and an active PBMT group of 11, with both groups completing 84 days of resistance training 2 times per week while an 850 nm laser delivering 240 J per limb was applied to the thighs before each session. The study reported that PBMT did not provide additional benefit over placebo for muscle strength, muscle thickness, or functional capacity in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 24
- Treated Area
- Leg
- Wavelength(s)
- 850 nm
- Session Frequency
- 2 per week
- Therapy Duration
- 84 days
Study Title: Effects of photobiomodulation therapy associated with resistance training in elderly men: a randomized double-blinded placebo-controlled trial.
Laser Therapy Showed No Benefit for Age-Related Muscle Loss
A randomized controlled human trial published in 2016 evaluated the effect of low-level laser therapy (LLLT) on muscle performance in elderly women with age-related muscle loss. The 48 participants were split into a control group of 15, a placebo LLLT group of 17 combined with strength training, and an active LLLT group of 16 combined with strength training, using an 808 nm laser applied to the thigh muscles in contact with the skin at 100 mW, 250 J/cm2 fluence, and 35700 mW/cm2 irradiance, for 70 seconds per session, 2 times per week, over 56 days. Researchers reported that LLLT was not effective overall for improving muscle performance in this trial.
- Study Type
- Randomized Controlled Trial
- Participants
- 48
- Treated Area
- Thigh
- Wavelength(s)
- 808 nm
- Distance
- Contact
- Session Duration
- 70 seconds
- Session Frequency
- 2 per week
- Therapy Duration
- 56 days
Study Title: Low level laser therapy associated with a strength training program on muscle performance in elderly women: a randomized double blind control study.
The CURE Index (Clinical Understanding of Red-light Evidence) by Helio Cure is a 0-100 evidence score based on published human clinical trials. Higher scores mean stronger evidence. Read full methodology →
Data is powered by AI and reviewed by the Helio Cure team.
This page is for educational purposes only. Not medical advice. Consult a healthcare provider before starting red light therapy. Helio Cure does not diagnose, treat, or cure any medical condition.
Last updated: Jul 20, 2026

